The Williams Cancer Difference, intratumoral immunotherapy and Pulsed Electrical Field Ablation

Targeted approach: Immunotherapy, cryoablation, and pulsed electrical field therapy all use a targeted approach to treat cancer. These treatments are designed to specifically target cancer cells, while leaving healthy cells unharmed. In contrast, conventional treatments like chemotherapy can damage healthy cells along with cancer cells, leading to unpleasant side effects.

Minimally invasive procedures: Immunotherapy, cryoablation, and pulsed electrical field therapy are minimally invasive procedures that require smaller incisions or no incisions at all. This reduces the risk of complications and leads to faster recovery times compared to conventional treatments like surgery.

Outpatient procedures: Immunotherapy, cryoablation, and pulsed electrical field therapy can often be performed on an outpatient basis, allowing patients to return home the same day. This is in contrast to conventional treatments like chemotherapy, which often require multiple rounds of treatment in a hospital or clinic setting.

Fewer side effects: Because immunotherapy, cryoablation, and pulsed electrical field therapy are targeted treatments that spare healthy cells, they tend to have fewer side effects than conventional treatments like chemotherapy. Patients receiving these treatments may experience less fatigue, hair loss, and other side effects commonly associated with chemotherapy.

Longer-lasting effects: Some studies suggest that immunotherapy may have longer-lasting effects than chemotherapy, potentially resulting in better long-term outcomes for patients. This is because immunotherapy can help the immune system recognize and fight cancer cells even after the initial treatment has ended.

Reference: Akshay Sood, M. A. (2018). Intratumoral Immunotherapy and Pulsed Electrical Field Ablation. Journal of Oncology Practice.